文献速递肾小球疾病

多中心队列研究:血红蛋白尿作为IgA肾病炎症标志物

A multi-center cohort study evaluated hemoglobinuria as a marker of inflammation in IgA nephropathy.
PubMed 文献 · Kidney Int · 2026-08-21

该多中心回顾性队列纳入441例活检证实的IgA肾病患者,评估试纸血红蛋白尿、显微镜血尿和蛋白尿与牛津MEST-C活动性病变的关联。血红蛋白尿与M1、E1及新月体病变相关,复合活动性病变的合并OR为2.28(95%CI 1.76-2.97),提示其可辅助评估疾病活动度。

要点

  • 试纸血红蛋白尿与IgA肾病活动性组织学病变独立相关。
  • 血红蛋白尿与复合活动性病变的合并OR为2.28(95%CI 1.76-2.97)。
  • 血红蛋白尿和血尿与慢性病变无关,蛋白尿与T1/T2病变相关。

核心结论

  • 试纸血红蛋白尿与IgA肾病活动性组织学标志物相关,可补充当前疾病活动度评估。

研究设计与样本

  • 多中心回顾性队列研究,纳入2015年7月至2025年7月活检证实的IgA肾病患者441例,均同期完成尿常规检查。
  • 采用未调整的队列特异性 logistic 回归评估关联,并用随机效应荟萃分析估计合并OR。

主要发现

  • 血红蛋白尿与M1病变合并OR 1.77(95%CI 1.25-2.51)、E1病变1.75(1.44-2.11)、新月体病变1.57(1.20-2.07)相关。
  • 血尿与M1病变合并OR 1.24(1.14-1.35)、E1病变1.22(1.13-1.31)、C1/C2病变1.18(1.09-1.28)相关。
  • 复合活动性病变(M1、E1和/或C1/C2)的合并OR:血红蛋白尿2.28(1.76-2.97)、血尿1.36(1.22-1.51)、蛋白尿1.20(1.04-1.38)。
  • 血红蛋白尿和血尿与慢性病变无关,蛋白尿与T1/T2病变相关(合并OR 1.35,95%CI 1.20-1.52)。

临床怎么用

  • 在IgA肾病风险评估中,可结合试纸血红蛋白尿辅助识别活动性组织学病变。

局限性

  • 回顾性设计,仅采用未调整的队列特异性 logistic 回归模型评估关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Hematuria is a hallmark clinical manifestation of IgA nephropathy (IgAN) and largely reflects underlying glomerular inflammation. Despite this, current guidelines prioritize proteinuria and estimated glomerular filtration rate for risk assessment, and the association between urinary findings and underlying histologic lesions remains incompletely characterized. METHODS: Here, we conducted a multicenter retrospective cohort study of patients with biopsy-proven IgAN (July 2015-July 2025) with concurrent urinalysis. Associations between hemoglobinuria (dipstick), hematuria (microscopy), proteinuria and individual Oxford Classification MEST-C components, and composite inflammatory lesions (M1, E1, and/or C1/C2; and E1 and/or C1/C2) were evaluated using unadjusted cohort-specific logistic regression models. Pooled odds ratios (ORs) were estimated using random-effects meta-analysis. RESULTS: Among 441 patients, hemoglobinuria was associated with M1 lesions (pooled OR 1.77, 95% CI 1.25-2.51), E1 lesions (1.75, 1.44-2.11), and crescentic lesions (1.57, 1.20-2.07). Hematuria was also associated with M1 lesions (1.24, 1.14-1.35), E1 lesions (1.22, 1.13-1.31), and C1/C2 lesions (1.18, 1.09-1.28). For the composite outcome (M1, E1, and/or C1/C2), pooled ORs were 2.28 (1.76-2.97) for hemoglobinuria, 1.36 (1.22-1.51) for hematuria, and 1.20 (1.04-1.38) for proteinuria. Hemoglobinuria and hematuria were not associated with chronic lesions, whereas proteinuria was consistently associated with T1/T2 lesions (1.35, 1.20-1.52). CONCLUSIONS: Dipstick hemoglobinuria is associated with histologic markers of active disease in IgAN and may provide clinically relevant information to complement current assessment of disease activity in IgAN.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Vargas-Brochero MJ, Cara A, Angioi A, et al. A multi-center cohort study evaluated hemoglobinuria as a marker of inflammation in IgA nephropathy. Kidney Int. 2026. PMID: 42628835. doi:10.1016/j.kint.2026.07.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。